Detalhe da pesquisa
1.
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.
Cancer
; 128(12): 2269-2280, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333400
2.
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial.
Prostate
; 81(6): 326-338, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33636027
3.
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
Prostate
; 80(5): 407-411, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31972048
4.
Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype.
Prostate
; 79(13): 1572-1579, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31389628
5.
Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
Immunity
; 32(2): 163-74, 2010 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20137987
6.
T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters.
Eur J Immunol
; 45(6): 1635-42, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25782169
7.
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.
NPJ Genom Med
; 9(1): 7, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253539
8.
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target across Human Malignancies.
Cancer Res Commun
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709075
9.
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
Sci Rep
; 14(1): 1458, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228729
10.
MLH1 Loss in Primary Prostate Cancer.
JCO Precis Oncol
; 7: e2200611, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196219
11.
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.
Nat Med
; 29(4): 888-897, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012549
12.
Rational development of high-affinity T-cell receptor-like antibodies.
Proc Natl Acad Sci U S A
; 106(14): 5784-8, 2009 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19307587
13.
Quantitating T cell cross-reactivity for unrelated peptide antigens.
J Immunol
; 183(7): 4337-45, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734234
14.
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088742
15.
Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features.
NPJ Precis Oncol
; 5(1): 38, 2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990660
16.
Reimagining Vaccines for Prostate Cancer: Back to the Future.
Clin Cancer Res
; 26(19): 5056-5058, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737029
17.
Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.
Eur Urol
; 75(3): 378-382, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30337059
18.
B7-H3 and Prostate Cancer: New Therapeutic Dance Partners.
Eur Urol
; 83(3): 239-240, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347717
19.
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation.
Urol Case Rep
; 17: 22-25, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29541580
20.
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Leuk Res
; 83: 106174, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31255938